EnteroMedics
Founded Year
2002Stage
IPO | IPOTotal Raised
$81.47MDate of IPO
11/14/2007Market Cap
0.04BAbout EnteroMedics
EnteroMedics (NASDAQ: ETRM) has developed vBloc® vagal blocking therapy, a unique, broadly patented therapeutic approach to treat a range of gastrointestinal and metabolic diseases. vBloc® is a first-in-class weight loss treatment that addresses the growing global health crises associated with obesity and its co-morbidities, such as diabetes and hypertension. vBloc® Therapy, delivered by a pacemaker-like device called the Maestro® Rechargeable System controls both hunger and fullness by blocking the primary nerve which regulates the digestive system. vBloc® Therapyaddresses the lifelong challenge of obesity by empowering people to take a positive path toward weight loss without compromising their lifestyle.
Missing: EnteroMedics's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: EnteroMedics's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing EnteroMedics
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
EnteroMedics is included in 1 Expert Collection, including Diabetes.
Diabetes
1,903 items
EnteroMedics Patents
EnteroMedics has filed 48 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
2/2/2017 | 12/27/2022 | Electrical signal connectors, Neuroscience, Millisecond pulsars, Pulsars, Neuroimaging | Grant |
Application Date | 2/2/2017 |
|---|---|
Grant Date | 12/27/2022 |
Title | |
Related Topics | Electrical signal connectors, Neuroscience, Millisecond pulsars, Pulsars, Neuroimaging |
Status | Grant |
Latest EnteroMedics News
Oct 14, 2022
Search jobs 14-Oct-2022 Bariatric Devices Market Size Research and Analysis Study With Enteromedics, GelesisAllergan, and Aspire Bariatrics As Key Vendors : Market.us Pune, Maharashtra, India, October 14 2022 (Wiredrelease) Prudour Pvt. Ltd –: Bariatric devices are experiencing a surge in demand due to the rising prevalence of obesity and associated chronic diseases. The increasing prevalence of obesity is the major factor driving the growth of the bariatric devices market. According to the World Health Organization, obesity has nearly tripled since 1975 globally, with more than 1.9 billion adults being overweight in 2016. Obesity is a major risk factor for various chronic diseases such as heart disease, stroke, diabetes, and certain types of cancer. The growing awareness about the health risks associated with obesity is leading to an increase in the number of people opting for bariatric surgery. Technological advancements are also driving the growth of the bariatric devices market. The report begins with a brief presentation and overview of the Bariatric Devices market, about the current market landscape, market trends, major market players, product type, application, and region. It also includes the impact of COVID-19 (Omicron) on the global Bariatric Devices market trends, future forecasts, growth opportunities, end-user industries, and market players. It also provides historical data, current market scenario and future insights on Bariatric Devices market. This study provides a comprehensive understanding of market value with the product price, demand, gross margin, and supply of the Bariatric Devices market. The competitive perspective section of the report presents a clear insight into the market share analysis of the major players in the industry. Competitive Spectrum – Top Companies Participating in the Bariatric Devices Market are: Medtronic Key regions divided during this report: – The Middle East and Africa Bariatric Devices Market (Saudi Arabia, United Arab Emirates, Egypt, Nigeria, South Africa) – North America Bariatric Devices Market (United States, Canada, Mexico) – Asia Pacific Bariatric Devices Market (China, Japan, Korea, India, Southeast Asia) – South America Bariatric Devices Market (Brazil, Argentina, Colombia) – Europe Bariatric Devices Market (Germany, UK, France, Russia, Italy) Click the link if you are planning to make a direct purchase @ https://market.us/purchase-report/?report_id=46497 The Bariatric Devices market research is sourced for experts in both primary and developed statistics and includes qualitative and quantitative details. The analysis is derived from Manufacturers’ experts work around the clock to recognize current circumstances, such as COVID-19, the possible financial reversal, the impact of a trade slowdown, the importance of the limitation on export and import, and all the other factors that may increase or decrease market growth during the forecast period. TOC Highlights: Chapter 1. Introduction The Bariatric Devices research work report covers a brief introduction to the global market. this segment provides opinions of key participants, an audit of Bariatric Devices industry, an outlook across key regions, financial services and various challenges faced by Bariatric Devices Market. This section depends on the Scope of the Study and Report Guidance. Chapter 2. Outstanding Report Scope This is the second most important chapter, which covers market segmentation along with a definition of Bariatric Devices. It defines the entire scope of the Bariatric Devices report and the various facets it is describing. Chapter 3. Market Dynamics and Key Indicators This chapter includes key dynamics focusing on drivers[ Includes Globally Growing Bariatric Devices Prevalence and Increasing Investments in Bariatric Devices, Key Market Restraints [High Cost of Bariatric Devices], opportunities [Emerging Markets in Developing Countries] and also presented in detail the emerging trends [Consistent Launch of New Screening Products] growth challenges, and influence factors shared in this latest report. Chapter 4. Type Segments This Bariatric Devices market report shows the market growth for various types of products marketed by the most comprehensive companies. Chapter 5. Application Segments The examiners who wrote the report have fully estimated the market potential of key applications and recognized future opportunities. Chapter 6. Geographic Analysis Each regional market is carefully scrutinized to understand its current and future growth, development, and demand scenarios for this market. 7.1 North America: Insight On COVID-19 (Omicron) Impact Study 2021 7.2 Europe: Serves Complete Insight On COVID-19 (Omicron) Impact Study 2021 7.3 Asia-Pacific: Potential Impact of COVID-19 (Omicron) 7.4 Rest of the World: Impact Assessment of COVID-19 (Omicron) Pandemic Chapter 8. Manufacturing Profiles The major players in the Bariatric Devices market are detailed in the report based on their market size, market service , products, applications, regional growth, and other factors. Chapter 9. Pricing Analysis Chapter 10. North America Bariatric Devices Market Analysis This chapter includes an assessment of Bariatric Devices product sales across major countries of the United States and Canada along with a detailed segmental outlook across these countries for the forecasted period 2022-2031. Chapter 11. Latin America Bariatric Devices Market Analysis Major countries of Brazil, Chile, Peru, Argentina, and Mexico are assessed apropos to the adoption of Bariatric Devices. Chapter 12. Europe Bariatric Devices Market Analysis Market Analysis of Bariatric Devices report includes insights on supply-demand and sales revenue of Bariatric Devices across Germany, France, United Kingdom, Spain, BENELUX, Nordic and Italy. Chapter 13. Asia Pacific Excluding Japan (APEJ) Bariatric Devices Market Analysis Countries of Greater China, ASEAN, India, and Australia & New Zealand are assessed and sales assessment of Bariatric Devices in these countries is covered. Chapter 14. The Middle East and Africa (MEA) Bariatric Devices Market Analysis This chapter focuses on Bariatric Devices market scenario across GCC countries, Israel, South Africa, and Turkey. Chapter 15. Research Methodology 15.1 Coverage
EnteroMedics Frequently Asked Questions (FAQ)
When was EnteroMedics founded?
EnteroMedics was founded in 2002.
Where is EnteroMedics's headquarters?
EnteroMedics's headquarters is located at 2800 Patton Road, Saint Paul.
What is EnteroMedics's latest funding round?
EnteroMedics's latest funding round is IPO.
How much did EnteroMedics raise?
EnteroMedics raised a total of $81.47M.
Who are the investors of EnteroMedics?
Investors of EnteroMedics include Western Technology Investment, MPM Capital, Bay City Capital, Charter Venture Capital, Aberdare Ventures and 6 more.
Who are EnteroMedics's competitors?
Competitors of EnteroMedics include iTind, Nyxoah, Mobius Therapeutics, Acelity, Cianna Medical and 13 more.
Compare EnteroMedics to Competitors
Beta-O2 Technologies is a biomedical company developing a proprietary implantable bioreactor, the ßAir. The company's flagship product is called the ßAir Bio-artificial Pancreas. It is in development as a treatment and potential cure for type 1 diabetes (T1D). ßAir was first designed to address the main problems of the otherwise successful procedures in which islets of Langerhans (i.e. pancreatic endocrine cells) are transplanted in diabetic patients, such as the need for life-long immunosuppressive pharmacological treatment and limited functionality of the transplanted islets over time due to an insufficient oxygen supply. The company's second pipeline product is the ßAir Bio-artificial Adrenal for the treatment of adrenocortical insufficiency and other stress-related disorders. This product is currently at the pre-clinical stage of development.
Portaero, in stealth mode, is a medical devices firm, developing a device for the treatment of COPD (Chronic obstructive pulmonary disease).
Apneon is an early stage medical device company developing devices for the treatment of sleep apnea.
Medical devices for the treatment of severe gastrointestinal disorders
Linguaflex is a medical device company with a patent pending technology to treat obstructive sleep apnea. LinguaFlex's LTR is implanted and designed to be comfortable, therefore addressing the lack of compliance as an issue in the successful treatment of OSA.
Accord Biomaterials aims to develop nitric oxide generating coatings for blood-contacting medical devices. Their coatings address serious complications related to clotting and altered healing, improving performance and reducing total costs of critical medical device interventions.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.